HUMAN FAECAL MATTER
Alopecia
Chinese University of Hong Kongother_biologicalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Alopecia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Trastuzumab Deruxtecan Jules Bordet Institute | Phase 2 | CCC |
Datopotamab Deruxtecan Jules Bordet Institute | Phase 2 | CCC |
Bimatoprost Jonsson Comprehensive Cancer Center | N/A | D |
Same molecule, other indications
HUMAN FAECAL MATTER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →